4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001470831-26-000883
President, COO & Interim CEO sold 17,500 shares at an average $22.90 ($400,716)
- President, COO & Interim CEO acquired 17,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohlhepp Ryan President, COO & Interim CEO | 2026-09-08 | Option exercise 10b5-1 | +17,500 | $3.79 | $66,322 | 199,141 | D |
| Cohlhepp Ryan President, COO & Interim CEO | 2026-09-08 | Sale 10b5-1 | −14,058 | $22.77 | $320,053 | 185,083 | D |
| Cohlhepp Ryan President, COO & Interim CEO | 2026-09-08 | Sale 10b5-1 | −3,442 | $23.43 | $80,663 | 181,641 | D |
| Derivatives | |||||||
| Cohlhepp Ryan President, COO & Interim CEO | 2026-09-08 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −17,500 | 34,252 | D | ||
| Open-market sales · 17,500 sh · avg $22.90 · $400,716 | |||||||
Loading xslF345X06/wk-form4_1789071782.xml…